For decades, millions of women have lived with a diagnosis called Polycystic Ovary Syndrome (PCOS). But recently, experts and patient advocates around the world agreed that this name didn’t capture what the condition truly is. And in May 2026, a landmark global consensus officially introduced a new name: Polyendocrine Metabolic Ovarian Syndrome (PMOS).
Why the name has changed and what it really means
Originally, the name Polycystic Ovary Syndrome focused on the observation of multiple small follicles (often mistaken for “cysts”) on the ovaries. Over time, however, researchers and clinicians realized that this term was incomplete and misleading:
-
Many women with the condition do not actually have ovarian cysts, and having small follicles on an ultrasound is not unique to this disorder.
-
The name suggested a problem limited to the ovaries, when in fact the condition involves complex hormonal and metabolic imbalances, including insulin resistance, androgen (male‑type hormone) excess, and disruptions in multiple endocrine pathways.
-
This narrow wording led to misunderstandings, underdiagnosis, and confusion for women and clinicians alike.
The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), was chosen to reflect exactly what ongoing research has shown: this is not just a “cystic” ovarian issue, but a system‑wide hormonal and metabolic condition affecting many aspects of health, from menstrual cycles and fertility to weight, metabolism, skin, and emotional well‑being.
PMOS: what each part of the name stands for
-
Polyendocrine: involving many hormonal systems, not just reproductive hormones.
-
Metabolic: recognizing that metabolic processes like insulin sensitivity are central to the condition.
-
Ovarian Syndrome: while the ovaries are affected, they are only part of the broader picture.
This updated terminology aligns the language with the science, and helps people understand that PMOS affects the whole body — not only fertility.
Why the change matters
Language shapes understanding. When a condition’s name is misleading:
✔ Women may not recognize symptoms or seek help early.
✔ Providers may overlook metabolic or emotional health aspects.
✔ Research and treatment innovations can be limited by narrow definitions.
By naming the condition for what it is - a polyendocrine metabolic condition - we open the door to better awareness, more precise diagnosis, and more effective, individualized care. Experts hope the change will also reduce stigma and help research funding follow where it’s most needed.
How common is PMOS?
PMOS affects roughly one in eight women of reproductive age worldwide, which translates to more than 170 million women. Despite this high prevalence, many women remain undiagnosed or misdiagnosed due to misconceptions rooted in outdated terminology.
What this means for women who want to have children
If you’re struggling with PMOS and hoping to conceive, you are not alone, and you are not without options. PMOS is one of the most common causes of irregular ovulation and can impact fertility, but it doesn’t define your chances of becoming a parent.
At Unica Clinic we are here to support you on the safest and most effective path for your body and your goals.